Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Tieno Huynh

Joined: 30/04/20

Comments by Tieno Huynh
Sos Ltd Feb 26, 2021 6:08PM ET
Change My Mind: Why I Believe Tesoro/HUMBL Is The Next Big Thing In Fintech
Sos Ltd Feb 26, 2021 1:30PM ET
$SOS Hindenberg Research again is posting unconfirmed information! $SOS Kevin O’Leary from Shark Tank & Berkshire are invested in SOS! These reports will be found incorrect! Don’t fall for another Short set up! They should really do more DD before releasing press like this and why haven’t they actually confirmed this with investors like Kevin O’ Leary or someone from the Company? It should be illegal for them to post these reports until all this information is actually confirmed with an actual person! They’ve done this in the past and a retrction doesn’t do anything for investors! Yet, they can continue to just retract their unconfirmed research!
AstraZeneca ADR Sep 25, 2020 6:10AM ET
Over in Europe, AstraZeneca (AZN) received partial immunity in a low-cost EU vaccine deal, while in return for a higher price paid for its vaccine,
Peloton Interactive Sep 18, 2020 11:04PM ET
Tickeron has a negative outlook on this ticker and predicts a further decline by more than 4.00% within the next month with a likelihood of 40%. During the last month, the daily ratio of advancing to declining volumes was 1.16 to 1.The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. PTON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.63) is normal, around the industry mean (4.88). P/E Ratio (0.00) is within average values for comparable stocks, (93.12). Projected Growth (PEG Ratio) (0.00) is also within normal values, averaging (2.27). Dividen
AstraZeneca ADR Sep 18, 2020 9:15AM ET
AZN $90-$120 today!!!!! Finally!! Google it yourself! Someone just bought 35,000 shares!! 3 catalyst this morning!!!
Peloton Interactive Sep 15, 2020 9:57AM ET
five have given a hold rating, twenty-six have issued a buy rating and one has issued a strong buy rating to the company.
Peloton Interactive Sep 15, 2020 8:27AM ET
Canaccord Genuity boosted their price objective on Peloton from $80.00 to $120.00 and gave the company a “buy” rating in a report on Friday. Raymond James boosted their price objective on Peloton from $65.00 to $109.00 and gave the company an “outperform” rating in a report on Friday. Robert W. Baird boosted their price objective on Peloton from $90.00 to $120.00 and gave the company an “outperform” rating in a report on Friday. Five have given a hold rating, twenty-six have issued a buy rating and one has issued a strong buy rating to the company.
Peloton Interactive Sep 15, 2020 8:23AM ET
Bank of Montreal increases Shares 1.7M.
Peloton Interactive Sep 15, 2020 8:07AM ET
Positive news release at 1pm ET. Pelaton to hit analyst targets $100-$129 today!
Peloton Interactive Sep 15, 2020 8:05AM ET
Peloton Interactive Sep 14, 2020 10:23AM ET
There doesn't seem to be any near-term obstacles to keep Peloton from hitting its goal of topping 2 million connected fitness subscribers by the end of the new fiscal year, a goal that would translate into at least 90% growth. Some of these fresh moves to reach a wider audience can mean that it's just scratching the surface. Peloton's stock isn't cheap by any measuring stick, but you have to pay up for the best growth stocks. Right now Peloton is one of the market's top speedsters, and for now that means the stock's future is as bright as its past.
AstraZeneca ADR Sep 03, 2020 12:33AM ET
Three vaccines are in Phase 3 clinical trials in the U.S. They are an AstraZeneca PLC vaccine developed with Oxford University, one from Moderna Inc., and a candidate from Pfizer Inc. and German-based BioNTech SE. AstraZeneca and Oxford University are conducting a Phase 3 study of their vaccine candidate in the U.K., South Africa and Brazil with several thousand volunteers. In a July conference call with reporters, AstraZeneca executives said results from that trial could be available sometime between September and November, depending on the severity of the pandemic in those countries. AstraZeneca said on the call that data from the study could be sufficient to gain emergency-use authorization in the U.S., if the data are strong enough. "We will be ready from a manufacturing viewpoint to start delivery," AstraZeneca Chief Executive Pascal Soriot said on the conference call. "The question is how quickly do we get a clinical readout and that's very much influenced by the infection rate
Hyliion Holdings Sep 01, 2020 4:33PM ET
I have 5,000 shares and buying more on dip! Once merges it will be over $100 easy. Market leader and 1st to market is major! Hold!!
AstraZeneca ADR Aug 25, 2020 12:03PM ET
UK study to assess AstraZeneca drug in diabetic COVID-19 patients
AstraZeneca ADR Aug 21, 2020 3:31PM ET
Seeking Alpha Catalyst Watch
AstraZeneca ADR Aug 21, 2020 8:32AM ET
AstraZeneca's Imfinzi OK'd in Japan for extensive-stage lung cancer
Sorrento Therape Aug 20, 2020 5:29PM ET
Sorrento Therapeutics May Bring Best In Class COVID-19 Tests
Cytodyn Inc Aug 20, 2020 9:16AM ET
CytoDyn on go with UK late-stage study of leronlimab for COVID-19
Duck Creek Aug 19, 2020 10:23AM ET
Value $50/share!
AstraZeneca ADR Aug 19, 2020 10:21AM ET
Let it be today! Stock finally get what it deserves and rockets! Should be more then NVAX!
AstraZeneca ADR Aug 19, 2020 10:20AM ET
"We are going with the initiative by the European Commission, which is negotiating with producers, and the negotiations are very advanced, we will very soon take part in (an agreement) with AstraZeneca (NYSE:AZN)." The EU agreed last week to buy at least 300 million doses of AstraZeneca's potential COVID-19 vaccine in its first such advance purchase deal, with others expected to follow. The Czech government has said it intends to initially vaccinate 3.5 million out of the country's 10.7 million population to cover medical and social services staff, elderly and ill citizens. It expects to purchase 7 million doses of a vaccine assuming two shots will be needed for each person.
INmune Bio Aug 13, 2020 10:54AM ET
INmune Bio nabs European patent for XPro1595
MGM Aug 12, 2020 3:05PM ET
Nascar, BetMGM to Offer Live Betting Starting 20218/11/20, 9:50 AMNascar and BetMGM, a sports-betting platform jointly owned by MGM Resorts International and GVC Holdings PLC, on Tuesday said they are partnering to offer in-race betting in the U.S. starting 2021.BetMGM, which is licensed for sports betting in seven states and plans to be in 11 states by the end of the year, will have rights to Nascar marks and promote Nascar offerings on its mobile app under the multi-year partnership.BetMGM said it will expand the types of bets offered on its app throughout the Nascar season, including pre-race and in-play bets. Top-finishing drivers, driver matchups, stage winners and bets tied to the winning car are among possible bets, it said.BetMGM will offer live, in-play betting through a partnership with Genius Sports and Betgenius, it said. Nascar and BetMGM are also developing a free-to- play Nascar game.Write to Dave Sebastian at
MGM Aug 12, 2020 3:01PM ET
Sorrento Therape Aug 11, 2020 6:21PM ET
Fake news shoudl be illegal! So tired of fake news and reports! Need to hold these people accountable for fake statements.